4//SEC Filing
Ogden Christopher 4
Accession 0001610717-24-000177
CIK 0001501989other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:38 PM ET
Size
4.7 KB
Accession
0001610717-24-000177
Insider Transaction Report
Form 4
Ogden Christopher
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-03-19$2.09/sh−2,971$6,196→ 85,686 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 60,310 restricted stock units.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001914523
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:38 PM ET
- Size
- 4.7 KB